Ledger.Open graph →
SEC Form D · filed August 3, 2020

Reiley Pharmaceuticals, Inc

Offering
$1.5M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jeffrey M. Dunn · San Francisco, CADirectorKeith M. Valentine · San Francisco, CADirectorB. M. Silber · San Francisco, CAExec · DirectorJames B. Lollar · Tulsa, OKDirectorMirko Dietz · Luxembourg, LuxembourgExec · DirectorMichael C. Evans · Tulsa, OKDirectorDustin Froyum · Minneapolis, MNDirectorMarc Sokol · Minneapolis, MNDirectorJohn Van Leeuwen · Lake Oswego, ORExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗